The contribution of the kidneys to postabsorptive endogenous glucose produc
tion is a matter of controversy. To assess whether this could relate to the
use of various isotopical methods with different analytical performance ca
pabilities, we measured glucose kinetics in 12 healthy subjects. Blood samp
les were taken from the femoral artery and the renal vein after 4 h of [B,6
-H-2(2)]glucose infusion (for gas chromatography [GC]/mass spectrometry [MS
I analysis), and renal plasma flow was determined with paraaminohippurate.
In addition, six subjects received uniformly labeled [C-13]glucose (for GC/
combustion/isotope ratio MS [IRMS]) and [3-H-3]glucose (for counting of rad
ioactive disintegrations). Arterial glucose concentrations (means +/- SD) w
ere 4.2 +/- 0.1 mmol/l, and endogenous glucose production rates using [H-2(
2)]glucose were 2.2 +/- 0.1 mg . kg(-1) . min(-1) or 818 +/- 50 mu mol/min.
Dilution of [H-2(2)]glucose across the kidney was 0.79 +/- 1.32%, and rena
l glucose production (RGP) rates were 27 +/- 72 mu mol/min. In the six subj
ects receiving additional tracers, dilutions across the kidney were 2.83 +/
- 0.72 and 0.54 +/- 1.20 (for [U-C-13]glucose and [3-H-3]glucose, respectiv
ely, the dilution with [U-C-13] being higher than that with [H-2(2)] (P = 0
.007). Corresponding BGP values were 144 +/- 39 and 43 +/- 76 mu mol/l min
for [U-C-13] and [3-H-3], respectively In conclusion, we found that the hig
hly sensitive [U-C-13] GC/Combustion/IRMS technique showed consistent dilut
ion of label across the kidney, whereas the less sensitive techniques gave
some negative values and smaller RGP rates. Thus, depending on which techni
que is being used, a fivefold difference in calculated RGP values may be en
countered. The methodological variability of our data suggests that extrapo
lation from regional renal measurements to the whale-body level should be p
erfumed with caution.